| Sarcoma derived from cultured mesenchymal stem cells J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, ... Stem cells 25 (2), 371-379, 2007 | 827 | 2007 |
| Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label … D Yannopoulos, J Bartos, G Raveendran, E Walser, J Connett, TA Murray, ... The lancet 396 (10265), 1807-1816, 2020 | 731 | 2020 |
| Osteopetrosis J Tolar, SL Teitelbaum, PJ Orchard New England Journal of Medicine 351 (27), 2839-2849, 2004 | 700 | 2004 |
| Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1–dependent mechanism that is up-regulated by interleukin-13 SL Highfill, PC Rodriguez, Q Zhou, CA Goetz, BH Koehn, R Veenstra, ... Blood, The Journal of the American Society of Hematology 116 (25), 5738-5747, 2010 | 518 | 2010 |
| Concise review: hitting the right spot with mesenchymal stromal cells J Tolar, K Le Blanc, A Keating, BR Blazar Stem cells 28 (8), 1446-1455, 2010 | 460 | 2010 |
| Bone marrow transplantation for recessive dystrophic epidermolysis bullosa JE Wagner, A Ishida-Yamamoto, JA McGrath, M Hordinsky, DR Keene, ... New England Journal of Medicine 363 (7), 629-639, 2010 | 431 | 2010 |
| The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro JH Arbuckle, MM Medveczky, J Luka, SH Hadley, A Luegmayr, D Ablashi, ... Proceedings of the National Academy of Sciences 107 (12), 5563-5568, 2010 | 407 | 2010 |
| Phase I/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft JE Wagner, CG Brunstein, AE Boitano, TE DeFor, D McKenna, D Sumstad, ... Cell stem cell 18 (1), 144-155, 2016 | 406 | 2016 |
| IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced … DA Vallera, M Felices, R McElmurry, V McCullar, X Zhou, JU Schmohl, ... Clinical Cancer Research 22 (14), 3440-3450, 2016 | 373 | 2016 |
| Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study M Aldenhoven, RF Wynn, PJ Orchard, A O’Meara, P Veys, A Fischer, ... Blood, The Journal of the American Society of Hematology 125 (13), 2164-2172, 2015 | 343 | 2015 |
| TALEN-based gene correction for epidermolysis bullosa MJ Osborn, CG Starker, AN McElroy, BR Webber, MJ Riddle, L Xia, ... Molecular Therapy 21 (6), 1151-1159, 2013 | 328 | 2013 |
| Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia Q Zhou, ME Munger, SL Highfill, J Tolar, BJ Weigel, M Riddle, AH Sharpe, ... Blood, The Journal of the American Society of Hematology 116 (14), 2484-2493, 2010 | 314 | 2010 |
| Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical … CG Brunstein, DJ Weisdorf, T DeFor, JN Barker, J Tolar, JAH van Burik, ... Blood 108 (8), 2874-2880, 2006 | 311 | 2006 |
| Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report WP Miller, SM Rothman, D Nascene, T Kivisto, TE DeFor, RS Ziegler, ... Blood, The Journal of the American Society of Hematology 118 (7), 1971-1978, 2011 | 298 | 2011 |
| Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia JE Wagner, J Tolar, O Levran, T Scholl, A Deffenbaugh, J Satagopan, ... Blood 103 (8), 3226-3229, 2004 | 265 | 2004 |
| Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases MJ Osborn, BR Webber, F Knipping, C Lonetree, N Tennis, AP DeFeo, ... Molecular Therapy 24 (3), 570-581, 2016 | 264 | 2016 |
| 3D printed functional and biological materials on moving freeform surfaces Z Zhu, SZ Guo, T Hirdler, C Eide, X Fan, J Tolar, MC McAlpine Advanced Materials 30 (23), 1707495, 2018 | 236 | 2018 |
| Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy HJ Deeg, M O'Donnell, J Tolar, R Agarwal, RE Harris, SA Feig, MC Territo, ... Blood 108 (5), 1485-1491, 2006 | 221 | 2006 |
| Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect M Felices, AJ Lenvik, R McElmurry, S Chu, P Hinderlie, L Bendzick, ... JCI insight 3 (3), 2018 | 220 | 2018 |
| Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning JJ Boelens, M Aldenhoven, D Purtill, A Ruggeri, T DeFor, R Wynn, ... Blood, The Journal of the American Society of Hematology 121 (19), 3981-3987, 2013 | 212 | 2013 |
Bruce BlazarVahvistettu sähköpostiosoite verkkotunnuksessa umn.edu
